Hudson Bay Capital Management LP Sio Gene Therapies Inc. Transaction History

Hudson Bay Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.28 - $0.44 $404,750 - $636,035	-1,445,536 Reduced 86.02%	235,000 $103,000
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $366 - $1,068	-1,464 Reduced 0.09%	1,680,536 $605,000
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $64,900 - $173,460	-118,000 Reduced 6.56%	1,682,000 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $251,550 - $460,200	195,000 Added 12.15%	1,800,000 $2.32 Million
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $117,650 - $175,500	65,000 Added 4.22%	1,605,000 $3.48 Million
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $124,199 - $173,400	-60,000 Reduced 3.75%	1,540,000 $4.2 Million
Q4 2020 Feb 12, 2021	BUY	$1.91 - $5.63 $3.06 Million - $9.01 Million	1,600,000 New	1,600,000 $4.45 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.